Lemmer E R, Bornman P C, Krige J E, Wright J P, Beningfield S, Jaskiewicz K, Kirsch R E, Kahn D, Terblanche J T, Robson S C
Gastrointestinal Clinic, Groote Schuur Hospital, University of Cape Town, South Africa.
Arch Surg. 1994 Jul;129(7):723-8. doi: 10.1001/archsurg.1994.01420310055009.
To review the outcome of a consecutive number of patients with primary sclerosing cholangitis (PSC) treated at one institution to define prognostic variables and determine the influence of surgery on outcome.
Case series of patients with PSC seen in Cape Town, South Africa, between 1981 and 1991.
Tertiary referral center.
Thirty-six patients with PSC were studied. Diagnosis was based on cholangiographic findings of multiple strictures of the bile ducts together with compatible clinical and biochemical features. Thirty-two patients were followed up prospectively for up to 9 years.
Patient outcome was defined as good (stable or slowly progressive disease) or poor (death or liver transplantation).
During the follow-up period, seven patients with PSC died and two underwent liver transplantation. Actuarial survival at 5 years was 52%. An increased serum bilirubin concentration was the only variable at presentation that independently predicted a poor outcome. Cholangiography was unhelpful in predicting patient outcome. Six patients who developed obstructive jaundice associated with advanced liver disease underwent biliary drainage operations for surgically correctable strictures, but this did not seem to prevent progression of the disease. Two patients who progressed to end-stage liver disease went on to have liver transplantation and were alive with functioning grafts at 7 and 14 months, respectively.
Symptomatic PSC is a progressive disorder with a poor prognosis. Our experience suggests that patients with advanced liver disease caused by PSC should be considered directly for liver transplantation rather than biliary bypass operations.
回顾在同一机构接受治疗的一系列原发性硬化性胆管炎(PSC)患者的治疗结果,以确定预后变量并确定手术对治疗结果的影响。
1981年至1991年间在南非开普敦诊治的PSC患者病例系列。
三级转诊中心。
对36例PSC患者进行了研究。诊断基于胆管造影显示的胆管多处狭窄以及相符的临床和生化特征。32例患者进行了长达9年的前瞻性随访。
患者治疗结果定义为良好(疾病稳定或缓慢进展)或不佳(死亡或肝移植)。
在随访期间,7例PSC患者死亡,2例接受了肝移植。5年实际生存率为52%。就诊时血清胆红素浓度升高是唯一能独立预测不良预后的变量。胆管造影对预测患者治疗结果并无帮助。6例因晚期肝病出现梗阻性黄疸的患者因可手术矫正的狭窄接受了胆道引流手术,但这似乎并未阻止疾病进展。2例进展至终末期肝病的患者继而接受了肝移植,分别在7个月和14个月时移植肝功能良好且存活。
有症状的PSC是一种预后不良的进行性疾病。我们的经验表明,由PSC导致晚期肝病的患者应直接考虑进行肝移植而非胆道搭桥手术。